高位赎回！多只次新基金“叫好不叫座”，什么情况？

Core Viewpoint - The article highlights the challenges faced by newly established funds in the context of high investor redemptions, leading to significant fund size reductions despite strong performance in the market [1][2][3]. Fund Redemption Issues - Many newly established funds are experiencing substantial redemptions, with some funds seeing up to 90% of their capital withdrawn, resulting in a shift from large funds to "mini funds" [4][5]. - A specific innovative drug industry fund reported a drop in assets from 47 million yuan at the end of March to 32 million yuan by the end of June, despite achieving a year-to-date return of nearly 50% [3][5]. - Another fund, which was established in late March, saw its assets decrease from over 200 million yuan to 17.52 million yuan, with over 90% of its capital redeemed [5][7]. Performance and Strategy - Despite the challenges, some funds have reported impressive returns, with certain funds in the innovative drug sector achieving returns of 136% and 110% year-to-date [8]. - The article notes that funds are increasingly diversifying their holdings, with some funds in unrelated sectors heavily investing in innovative drug stocks, leading to significant returns [8][9]. - Fund managers are advised to focus on long-term investment strategies and avoid concentrating assets in a single type of fund, especially during the performance verification period of semi-annual reports [9]. Market Outlook - There is a growing sentiment among fund managers regarding the need for a shift between high and low-performing sectors, as the current market shows signs of high concentration and potential volatility [10][11]. - Economic growth is expected to slow down in the second half of the year, leading to further performance differentiation among listed companies [11][12]. - Fund managers emphasize the importance of defensive strategies and caution against excessive risk-taking in the current market environment [12].